FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 4112864 · Received September 24, 2014

Report

Report Number
9612164-2014-01232
Event Type
Injury
Date Received
September 24, 2014
Date of Event
February 21, 2012
Report Date
January 13, 2015
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVALUATION RESULTS: INHERENT RISK OF PROCEDURE ¿ (MYOCARDIAL INFARCTION). EVALUATION CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (MYOCARDIAL INFARCTION). (B)(4).

Additional Manufacturer Narrative · 1

RESULTS: MYOCARDIAL INFARCTION. CONCLUSIONS: MYOCARDIAL INFARCTION. (B)(4).

Description of Event or Problem · 1

THE CEC ADJUDICATED THAT THE PATIENT SUFFERED A NON TARGET VESSEL MI (MDT AND ARC DEFINED) APPROXIMATELY 29 MONTHS POST INDEX PROCEDURE. THE SITE REPORTED THAT THE PATIENT SUFFERED ANOTHER MI APPROXIMATELY 5 DAYS LATER. THE INVESTIGATOR ASSESSED THAT THE EVENT WAS REMOTELY RELATED TO THE STUDY DEVICE. PATIENT IS REPORTED TO HAVE RECOVERED.

Description of Event or Problem · 1

DURING THE INDEX PROCEDURE THE PATIENT HAD AN ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT IMPLANTED IN THE MID LCX. IT IS REPORTED THAT APPROXIMATELY 56 MONTHS POST INDEX PROCEDURE THE PATIENT SUFFERED MYOCARDIAL INFARCTION. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. THE PATIENT WAS TREATED WITH MEDICATION. IT IS REPORTED THAT THE PATIENT RECOVERED WITH TREATMENT.

Description of Event or Problem · 1

ADDITIONAL INFORMATION RECEIVED REPORTED THAT THE PREVIOUSLY REPORTED MYOCARDIAL INFARCTION EVENT OCCURRED 2 DAYS PRIOR TO THE DATE PREVIOUSLY REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
596175 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00060 YR Required Intervention